Angiotensin‐converting enzyme inhibitors (ACEI) and angiotensin blockers (ARB) are a cornerstone in the treatment of hypertension, mainly when administered to patients with increased RAS activity as hypertensives with overweight or obesity.7 This evidence concerns the gene ACE and hypertensive disorder.